Skip to main content

Advertisement

ADVERTISEMENT

News

News
08/04/2020
Findings from a recent study published in JAMA Dermatology add to research that shows an increased risk of bullous pemphigoid among patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors.
Findings from a recent study published in JAMA Dermatology add to research that shows an increased risk of bullous pemphigoid among patients with type 2 diabetes treated with dipeptidyl peptidase-4 inhibitors.
Findings from a recent study...
08/04/2020
Autoimmune
News
07/31/2020
The presence of drug-induced neutralizing antibodies against tumor necrosis factor-α inhibitors may be a reliable biomarker for assessing treatment efficacy in patients with inflammatory joint diseases, a recent study shows.
The presence of drug-induced neutralizing antibodies against tumor necrosis factor-α inhibitors may be a reliable biomarker for assessing treatment efficacy in patients with inflammatory joint diseases, a recent study shows.
The presence of drug-induced...
07/31/2020
Autoimmune

Advertisement

News
07/30/2020
Researchers applied updated classification criteria for systemic lupus erythematosus to a group of patients previously described as having undifferentiated connective tissue disease in order to see if they could reclassify any cases as...
Researchers applied updated classification criteria for systemic lupus erythematosus to a group of patients previously described as having undifferentiated connective tissue disease in order to see if they could reclassify any cases as...
Researchers applied updated...
07/30/2020
Autoimmune
News
07/29/2020
Findings from a recent study showed a dose-dependent association between the risk of developing type 2 diabetes and glucocorticoid use among patients with common immune-mediated diseases.
Findings from a recent study showed a dose-dependent association between the risk of developing type 2 diabetes and glucocorticoid use among patients with common immune-mediated diseases.
Findings from a recent study...
07/29/2020
Autoimmune
News
07/27/2020
Smoking is a known risk factor in cardiovascular disease and several cancers. But what impact, if any, does smoking have on rheumatoid arthritis? A new study supplies some answers.
Smoking is a known risk factor in cardiovascular disease and several cancers. But what impact, if any, does smoking have on rheumatoid arthritis? A new study supplies some answers.
Smoking is a known risk factor...
07/27/2020
Autoimmune

Advertisement

News
07/24/2020
Findings from a recent analysis of phase 3 AMAGINE-2 and AMAGINE-3 trials showed greater benefit with brodalumab compared with ustekinumab for patients with psoriasis.
Findings from a recent analysis of phase 3 AMAGINE-2 and AMAGINE-3 trials showed greater benefit with brodalumab compared with ustekinumab for patients with psoriasis.
Findings from a recent analysis...
07/24/2020
Autoimmune
News
07/21/2020
Findings from a recent study suggested patients’ age and brainstem involvement at the onset of multiple sclerosis may be associated with alemtuzumab-related thyroid disease.
Findings from a recent study suggested patients’ age and brainstem involvement at the onset of multiple sclerosis may be associated with alemtuzumab-related thyroid disease.
Findings from a recent study...
07/21/2020
Autoimmune
News
07/21/2020
Findings from a recent study showed patients with nonclassical and classical presentations of celiac disease benefited from a gluten-free diet.
Findings from a recent study showed patients with nonclassical and classical presentations of celiac disease benefited from a gluten-free diet.
Findings from a recent study...
07/21/2020
Autoimmune

Advertisement

News
07/16/2020
Findings from a recent study suggest patients with certain inflammatory skin diseases, including atopic dermatitis, may have an increased risk for venous thromboembolism.
Findings from a recent study suggest patients with certain inflammatory skin diseases, including atopic dermatitis, may have an increased risk for venous thromboembolism.
Findings from a recent study...
07/16/2020
Autoimmune
News
07/12/2020
The array of therapeutic agents available for treating psoriatic arthritis has increased significantly. But how do rheumatologists determine which medications are best? Joseph F. Merola, MD, reviewed options at IAS 2020.
The array of therapeutic agents available for treating psoriatic arthritis has increased significantly. But how do rheumatologists determine which medications are best? Joseph F. Merola, MD, reviewed options at IAS 2020.
The array of therapeutic agents...
07/12/2020
Autoimmune

Advertisement